- Home
- CZWI vs IPHA Comparison
CZWI vs IPHA Comparison
Compare CZWI & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZWI
- IPHA
- Stock Information
- Founded
- CZWI 1938
- IPHA 1999
- Country
- CZWI United States
- IPHA France
- Employees
- CZWI N/A
- IPHA N/A
- Industry
- CZWI Savings Institutions
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- CZWI Finance
- IPHA Health Care
- Exchange
- CZWI Nasdaq
- IPHA Nasdaq
- Market Cap
- CZWI 162.8M
- IPHA 160.1M
- IPO Year
- CZWI N/A
- IPHA 2019
- Fundamental
- Price
- CZWI $16.28
- IPHA $2.05
- Analyst Decision
- CZWI
- IPHA Strong Buy
- Analyst Count
- CZWI 0
- IPHA 1
- Target Price
- CZWI N/A
- IPHA $11.00
- AVG Volume (30 Days)
- CZWI 14.7K
- IPHA 14.6K
- Earning Date
- CZWI 10-27-2025
- IPHA 09-17-2025
- Dividend Yield
- CZWI 2.23%
- IPHA N/A
- EPS Growth
- CZWI N/A
- IPHA N/A
- EPS
- CZWI 1.24
- IPHA N/A
- Revenue
- CZWI $58,007,000.00
- IPHA $14,839,695.00
- Revenue This Year
- CZWI N/A
- IPHA $350.96
- Revenue Next Year
- CZWI $11.90
- IPHA $32.92
- P/E Ratio
- CZWI $13.04
- IPHA N/A
- Revenue Growth
- CZWI N/A
- IPHA N/A
- 52 Week Low
- CZWI $12.69
- IPHA $1.29
- 52 Week High
- CZWI $17.04
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- CZWI 55.14
- IPHA 46.87
- Support Level
- CZWI $16.06
- IPHA $1.93
- Resistance Level
- CZWI $16.67
- IPHA $2.19
- Average True Range (ATR)
- CZWI 0.26
- IPHA 0.11
- MACD
- CZWI -0.08
- IPHA -0.01
- Stochastic Oscillator
- CZWI 34.38
- IPHA 49.66
About CZWI Citizens Community Bancorp Inc.
Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short- term investments; and funds provided from operations.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.